FINWIRES · TerminalLIVE
FINWIRES

International Business Machines Could Raise 2026 Revenue Outlook After Potential Q1 Beat, Oppenheimer Says

-- International Business Machines (IBM) could raise its 2026 revenue outlook and top Q1 expectations given its strong software business and early close of its Confluent acquisition, Oppenheimer said in a Thursday note.

Oppenheimer said its contract checks indicated that IBM's enterprise license agreements, or ELAs, saw a 20% to 30% increase in pricing for renewals in Q1, without customer attrition. RedHat contract values also increased 10% to 15% on renewals, the investment firm noted.

The company's software portfolio is positioned for a 7% growth in 2026, supported by pricing and deal sizes, the brokerage said. IBM's consulting business is also poised to grow 2.1% in 2026, Oppenheimer added.

IBM is set to release its Q1 results on April 22.

Oppenheimer lowered its price target on IBM to $320 from $380, with an outperform rating.

Price: $247.66, Change: $+2.86, Percent Change: +1.17%

相關文章

Asia

勝利巨頭科技透過行使IPO超額配售選擇權,募集30億港元。

根據香港交易所當日發布的公告顯示,勝利巨創科技(港交所代碼:2476,滬交所代碼:300476)表示,其香港首次公開募股(IPO)的超額配售選擇權已於週三全部行使。 這家總部位於中國的印刷電路板製造商預計將額外募集約30億港元的淨收益。 此次超額配售涉及以每股209.88港元的價格增發1440萬股,約佔全球發行總股數的15%。 公告稱,超額配售股份預計將於4月27日開始交易。

$HKG:2476$SHE:300476
Asia

Arovella Therapeutics稱,要求增發股份的股東撤回了增發股份的通知,股價下跌3%。

根據週四提交給澳洲證券交易所的文件顯示,Arovella Therapeutics(ASX:ALA)表示,要求召開股東大會以任命三名董事的股東已撤回其4月8日發出的通知。 Arovella Therapeutics此前曾表示,該通知“無法在股東大會上合法生效”,並已邀請該股東正式撤回通知。 該公司股價在周四的交易中下跌了3%。

$ASX:ALA
Asia

藍天科技2025年獲利下滑3%,營收成長5%

根據週四在上海證券交易所發布的公告,中國電子藍天科技(SHA:688818)預計2025年歸屬於股東的淨利潤將年減3%至3.271億元人民幣,而去年同期為3.372億元。 每股盈餘較去年同期下降4.5%至0.21元人民幣,而去年同期為0.22元。 營業收入較去年同期成長5.1%至32.9億元人民幣,去年同期為31.3億元。

$SHA:688818